BACKGROUND: We hypothesized that serum magnesium (Mg) is associated with increased risk of sudden cardiac death (SCD). METHODS: The Atherosclerosis Risk in Communities Study assessed risk factors and levels of serum Mg in a cohort of 45- to 64-year-old subjects in 1987-1989 (n = 14,232). After an average of 12 years of follow-up, we observed 264 cases of SCD, as determined by physician review of all suspected cases. We used proportional hazards regression to evaluate the association of serum Mg with risk of SCD. RESULTS: Individuals in the highest quartile of serum Mg were at significantly lower risk of SCD in all models. This association persisted after adjustment for potential confounding variables, with an almost 40% reduced risk of SCD (hazard ratio 0.62, 95% CI 0.42-0.93) in quartile 4 versus 1 of serum Mg observed in the fully adjusted model. CONCLUSIONS: This study suggests that low levels of serum Mg may be an important predictor of SCD. Further research into the effectiveness of Mg supplementation for those considered to be at high risk for SCD is warranted. 2010 Mosby, Inc. All rights reserved.
BACKGROUND: We hypothesized that serum magnesium (Mg) is associated with increased risk of sudden cardiac death (SCD). METHODS: The Atherosclerosis Risk in Communities Study assessed risk factors and levels of serum Mg in a cohort of 45- to 64-year-old subjects in 1987-1989 (n = 14,232). After an average of 12 years of follow-up, we observed 264 cases of SCD, as determined by physician review of all suspected cases. We used proportional hazards regression to evaluate the association of serum Mg with risk of SCD. RESULTS: Individuals in the highest quartile of serum Mg were at significantly lower risk of SCD in all models. This association persisted after adjustment for potential confounding variables, with an almost 40% reduced risk of SCD (hazard ratio 0.62, 95% CI 0.42-0.93) in quartile 4 versus 1 of serum Mg observed in the fully adjusted model. CONCLUSIONS: This study suggests that low levels of serum Mg may be an important predictor of SCD. Further research into the effectiveness of Mg supplementation for those considered to be at high risk for SCD is warranted. 2010 Mosby, Inc. All rights reserved.
Authors: W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer Journal: Am J Epidemiol Date: 1985-07 Impact factor: 4.897
Authors: Rebecca B Costello; Ronald J Elin; Andrea Rosanoff; Taylor C Wallace; Fernando Guerrero-Romero; Adela Hruby; Pamela L Lutsey; Forrest H Nielsen; Martha Rodriguez-Moran; Yiqing Song; Linda V Van Horn Journal: Adv Nutr Date: 2016-11-15 Impact factor: 8.701
Authors: Liana C Del Gobbo; Fumiaki Imamura; Jason H Y Wu; Marcia C de Oliveira Otto; Stephanie E Chiuve; Dariush Mozaffarian Journal: Am J Clin Nutr Date: 2013-05-29 Impact factor: 7.045
Authors: Di Zhao; Wendy S Post; Elena Blasco-Colmenares; Alan Cheng; Yiyi Zhang; Rajat Deo; Roberto Pastor-Barriuso; Erin D Michos; Nona Sotoodehnia; Eliseo Guallar Journal: Circulation Date: 2019-04-02 Impact factor: 29.690
Authors: Suma H Konety; Ryan J Koene; Faye L Norby; Tony Wilsdon; Alvaro Alonso; David Siscovick; Nona Sotoodehnia; John Gottdiener; Ervin R Fox; Lin Y Chen; Selcuk Adabag; Aaron R Folsom Journal: Circ Cardiovasc Imaging Date: 2016-08 Impact factor: 7.792
Authors: Yan Chen; Alex R Chang; Mara A McAdams DeMarco; Lesley A Inker; Kunihiro Matsushita; Shoshana H Ballew; Josef Coresh; Morgan E Grams Journal: Mayo Clin Proc Date: 2016-08-04 Impact factor: 7.616
Authors: Anne M Noonan; Robin A Eisch; David J Liewehr; Tristan M Sissung; David J Venzon; Thomas P Flagg; Mark C Haigney; Seth M Steinberg; William D Figg; Richard L Piekarz; Susan E Bates Journal: Clin Cancer Res Date: 2013-04-15 Impact factor: 12.531